About Finorion Pharma India Private Limited
Data last updated:
Finorion Pharma India Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Orion Corporation. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 23 December 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74120MH2011PTC225361. Its GSTIN is 27AABCF8675Q1ZQ (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Olli Heikki Huotari and Samrudhi Mangesh Utturkar.
Its last annual general meeting (AGM) was held on 22 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Smartworks Coworking Location Times Square Building, 9th Floor C Wing Andheri Marol Andheri East Mumbai, Maharashtra, India – 400059.
As per the financials filed for FY 2025, the company reported a revenue of ₹38.28 Cr, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹4.61 Cr (net margin 12%) and EBITDA of ₹6.71 Cr (EBITDA margin 17.5%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 9% over five years.
The company has about 204 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: FinOrion Pharma. Court records list 6 cases involving the company, including 6 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website orionpharma.in.
Company details
Contact details
Finorion Pharma India Private Limited's registered office is in Mumbai, Maharashtra. Its website is orionpharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressSmartworks Coworking Location Times Square Building, 9th Floor C Wing Andheri Marol Andheri East Mumbai, Maharashtra, India – 400059
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Finorion Pharma India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Finorion Pharma India operates one associated brand: FinOrion Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical development, manufacturing, and supply chain management in India. | orionpharma.in |
Business activity
The main business activity of Finorion Pharma India is support service to organizations. In detail, this covers other support services to organizations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| N | Support service to Organizations | N7 | Other support services to organizations |
To see the full business activity and turnover split of Finorion Pharma India Private Limited, buy the company report.
Financials of Finorion Pharma India Private Limited
FY 2025 filings availableFinorion Pharma India Private Limited reported revenue of ₹38.28 Cr (up 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 8% growth in the latest year. EBITDA fell 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.71 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.61 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.5% | ||||
| Net Profit Margin | 12% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Finorion Pharma India Private Limited, buy the company report.
Board of directors of Finorion Pharma India Private Limited
Finorion Pharma India has 6 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Olli Heikki Huotari | Director | 23 Dec 2011 | 14 Years 10 Months | Current |
| Samrudhi Mangesh Utturkar | Director | 29 May 2018 | 8 Years 5 Months | Current |
| Rene Kristian Lindell | Director | 05 Aug 2024 | 2 Years 3 Months | Current |
| Johanna Linnea Pakkanen | Director | 24 Nov 2015 | 10 Years 11 Months | Current |
| Mikko Tapani Kemppainen | Director | 24 Apr 2025 | 1 Years 6 Months | Current |
| Pekka Juhani Kankaanpaa | Director | 24 Apr 2025 | 1 Years 6 Months | Current |
Auditor
Finorion Pharma India Private Limited is audited by BSR & CO. LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BSR & CO. LLP | FY 2023 | 101248W/W-100022 |
Shareholding
The shareholding of Finorion Pharma India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Finorion Pharma India Private Limited, buy the company report.
Legal cases
Finorion Pharma India Private Limited has 6 court cases on record: 6 filed by Finorion Pharma India. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 0 | 0 |
| High courts | 2 | 0 | 0 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Writ petition | Filed by the company against State of Maharashtra and 2 others | Disposed |
| High Court, MAHARASHTRA | Writ petition | Filed by the company against State of Maharashtra Through Secretary, Department of GST and 3 others | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Court case (Chamber Summons) | Filed by the company against an individual | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Court case (Summons For Judgement) | Filed by the company against an individual | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Court case (Sum.Civ.Suit) | Filed by the company against individuals | Disposed |
To see the full case history of Finorion Pharma India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Finorion Pharma India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Finorion Pharma India Private Limited has a workforce of 204 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 204 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 | |
| FY 2015-16 |
To see the full employee and EPFO history of Finorion Pharma India Private Limited, buy the company report.
GST
Finorion Pharma India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCF8675Q1ZQ | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Finorion Pharma India Private Limited, buy the company report.
Recent activity
Finorion Pharma India Private Limited has 16 board changes on record since 2011: 6 appointments and 10 cessations. The latest: Mikko Tapani Kemppainen ceased to be Additional Director on 21 Sep 2025.
7 earlier events are in the company report.
Frequently asked questions
Finorion Pharma India is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 23 December 2011 (15+ years old) and is registered under CIN U74120MH2011PTC225361.
Finorion Pharma India has 6 current directors:
- Olli Heikki Huotari - Director
- Samrudhi Mangesh Utturkar - Director
- Rene Kristian Lindell - Director
- Johanna Linnea Pakkanen - Director
- Mikko Tapani Kemppainen - Director
- Pekka Juhani Kankaanpaa - Director
The latest financial statements of Finorion Pharma India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 22 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Finorion Pharma India is 27AABCF8675Q1ZQ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Finorion Pharma India is U74120MH2011PTC225361. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Finorion Pharma India has 6 court cases on record: 6 filed by the company. Most are in the district courts.
Finorion Pharma India was incorporated on 23 December 2011, making it 15+ years old. It is registered with the Registrar of Companies, Mumbai.
Mikko Tapani Kemppainen ceased to be Additional Director on 21 Sep 2025. Pekka Juhani Kankaanpaa ceased to be Additional Director on 21 Sep 2025. Mikko Tapani Kemppainen was appointed as Director on 24 Apr 2025. Finorion Pharma India has 16 board changes on record in total.
Finorion Pharma India can be reached through the website orionpharma.in. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Finorion Pharma India is at Smartworks Coworking Location Times Square Building, 9th Floor C Wing Andheri Marol Andheri East Mumbai, Maharashtra, India – 400059.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
